STOCK TITAN

UL Solutions director now holds 2,213 RSUs

Director Sally Susman received small dividend-equivalent RSU and DRSU accruals tied to existing UL Solutions equity awards.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. SUSMAN SALLY reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director Sally Susman received small equity-based awards on September 10, 2026, in the form of 10 Deferred Restricted Stock Units (DRSUs), an additional 5 DRSUs, and 4 Restricted Stock Units (RSUs), each representing one share of Class A Common Stock. The awards reflect accrued dividend equivalent rights on DRSUs and RSUs already held. Following the RSU-related accrual, Susman directly holds 2,213 RSUs, including associated dividend equivalents, which vest by the earlier of May 20, 2027 or the next annual meeting after May 20, 2026. No Rule 10b5-1 trading plan is reported for these transactions.

Positive

  • None.

Negative

  • None.
Insider SUSMAN SALLY
Role Director
Type Security Shares Price Value
Grant/Award Deferred Restricted Stock Units F1, F2, F3, F4 10 $0.00 $0.00
Grant/Award Deferred Restricted Stock Units F1, F2, F5, F4 5 $0.00 $0.00
Grant/Award Restricted Stock Units F1, F6, F7, F8 4 $0.00 $0.00
Holdings After Transaction: Deferred Restricted Stock Units — 7,793 contracts (Direct); Restricted Stock Units — 2,213 contracts (Direct)
Footnotes (8)
  1. F1. Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  2. F2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
  3. F3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
  4. F4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
  5. F5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
  6. F6. Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person.
  7. F7. The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.
  8. F8. Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date.
Deferred Restricted Stock Units granted (block 1) 10 units DRSUs acquired on September 10, 2026 via dividend equivalent accruals
Deferred Restricted Stock Units granted (block 2) 5 units Additional DRSUs acquired on September 10, 2026 via dividend equivalent accruals
Restricted Stock Units granted 4 units RSUs acquired on September 10, 2026 via dividend equivalent accruals
RSUs held after transaction 2,213 units Direct RSU holdings including accrued dividend equivalents after September 10, 2026
DRSU vesting date (first tranche) May 1, 2025 DRSUs related to some dividend equivalent rights vested on this date
DRSU vesting date (second tranche) May 20, 2026 Additional DRSUs related to dividend equivalent rights vested on this date
RSU vesting date May 20, 2027 RSUs vest on this date or the date of the annual meeting following May 20, 2026, whichever is earlier
Deferred Restricted Stock Units financial
"Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person."
Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.
Restricted Stock Units financial
"Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalent rights financial
"Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person."
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
Non-Employee Director Deferred Compensation Plan financial
"pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan")"
Class A Common Stock financial
"receive one share of the Issuer's Class A Common Stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did UL Solutions Inc. (ULS) director Sally Susman receive on September 10, 2026?

On September 10, 2026, Sally Susman received 10 DRSUs, an additional 5 DRSUs, and 4 RSUs, each representing a contingent right to one share of Class A Common Stock. These reflect accrued dividend equivalent rights on existing awards.

How many UL Solutions (ULS) RSUs does Sally Susman hold after the reported Form 4 transactions?

After the reported transactions, Sally Susman directly holds 2,213 RSUs, including all dividend equivalent rights that have accrued on those RSUs to date, each representing a contingent right to receive one share of Class A Common Stock.

What do the DRSU grants to the UL Solutions (ULS) director represent?

The DRSU grants represent dividend equivalent rights accrued on Deferred Restricted Stock Units already held. Each DRSU corresponds to a contingent right to receive one share of Class A Common Stock and is included with all accrued dividend equivalents on those DRSUs.

When will Sally Susman’s UL Solutions (ULS) RSUs from this filing vest?

The RSUs related to the dividend equivalent rights vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026 grant date, and will then be settled in shares of Class A Common Stock.

When did the UL Solutions (ULS) DRSUs tied to these dividend equivalents vest?

The DRSUs to which these dividend equivalent rights relate vested on May 1, 2025 and May 20, 2026. Settlement will occur in Class A Common Stock on a date selected under the Non-Employee Director Deferred Compensation Plan or as otherwise provided by that plan.

Were the UL Solutions (ULS) director’s transactions under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 plan checkbox is not marked, so these reported acquisitions of DRSUs and RSUs were not affirmed as made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SUSMAN SALLY

(Last)(First)(Middle)
C/O UL SOLUTIONS INC.
333 PFINGSTEN ROAD

(Street)
NORTHBROOK ILLINOIS 60062

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UL Solutions Inc. [ ULS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Restricted Stock Units(1)09/10/2026A10(2) (3) (3)Class A Common Stock10$04,979(4)D
Deferred Restricted Stock Units(1)09/10/2026A5(2) (5) (5)Class A Common Stock5$02,814(4)D
Restricted Stock Units(1)09/10/2026A4(6) (7) (7)Class A Common Stock4$02,213(8)D
Explanation of Responses:
1. Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
6. Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person.
7. The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.
8. Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date.
/s/ Ryan Robinson, Attorney-in-Fact09/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading